Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1

Status

Unknown 8Not yet recruiting 3Completed 3Terminated 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 116Gastrointestinal 35Sarcoma 6Lymphoid 6Thoracic 4Other solid neoplasm 4Gynecologic 4Tumor-Agnostic 3Genitourinary 3Other hematologic neoplasm 2Head & Neck 1Dermatologic 1CNS 1

Conditions

Testicular Neoplasms 2Non-Muscle Invasive Bladder Neoplasms 1Neoplasms, Germ Cell and Embryonal 1

Interventions

Docetaxel 205Prednisone 151enzalutamide 128Gemcitabine 123Radiotherapy 117Sunitinib 112Cisplatin 103Leuprolide 98pembrolizumab 96Abiraterone Acetate 94bicalutamide 87Nivolumab 85Goserelin 83Sorafenib 80Paclitaxel 79Carboplatin 77Everolimus 72Bevacizumab 71Magnetic Resonance Spectroscopy 66acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 61pazopanib 56radium Ra 223 dichloride 50Ipilimumab 49Zoledronic Acid 47Cyclophosphamide 44Radiosurgery 43Filgrastim 42abiraterone 41gallium 68 PSMA-11 40Surveys and Questionnaires 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Epirubicin × Genitourinary × Clear all
NCT06309732 2024-03-13

GAMEC-II

Queen Mary University of London

Phase 2 Completed
36 enrolled
Genitourinary

Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms

NCT02214602 2018-03-22

NMIBCIVT

Mansoura University

Phase 4 Completed
240 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT00231582 2011-02-25

High-dose Chemotherapy With Autologous Stem Cell Transplantation in Poor Prognosis Germ-cell Tumors: TAXIF II

Assistance Publique - Hôpitaux de Paris

Phase 2 Completed
50 enrolled
Genitourinary

Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡